Revenue
22.2 million USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 22183000 USD Source
Fundies. English
INTEGRATED SURGICAL SYSTEMS INC
EDGARAnnual consolidated revenue for 2025: about USD 134.8M, using the latest reported figures. The previous period, 2024, was about USD 125.9M.
Latest quarter
Operating margin
10.28%
2026 Q2 · %
Operating cash flow
90 thousand USD
2026 Q2 · USD
- Cash and cash equivalents
- 11.2 million USD Source
Exact value
11170000 USD
- Long-term debt including current maturities
- 97.6 million USD Source
Exact value
97606000 USD
- Shares outstanding
- 47.6 million shares Source
Exact value
47610653 shares
Reported share-count change
0.10% · 46 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
101 million USD
2025-07-01 – 2026-06-30
Net income
9.37 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Operating cash flow
27.3 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
- Operating cash flow: 26131000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 13970000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: 39246000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 26131000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 1961000 USD · 2026-01-01 – 2026-03-31 Source
- Operating cash flow: 2051000 USD · 2026-01-01 – 2026-06-30 Source
- Operating cash flow: 1961000 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-10.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 9 of 11 periods available· newest 2025-12-31
- Operating income: 10 of 11 periods available· newest 2025-12-31
- Net income: 10 of 11 periods available· newest 2025-12-31
- Operating cash flow: 10 of 11 periods available· newest 2025-12-31
- Capital expenditure: 8 of 11 periods available· newest 2025-12-31
- Total assets: 9 of 11 periods available· newest 2025-12-31
- Total liabilities: 9 of 11 periods available· newest 2025-12-31
- Current assets: 9 of 11 periods available· newest 2025-12-31
- Current liabilities: 9 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 9 of 11 periods available· newest 2025-12-31
- Long-term debt including current maturities: 8 of 11 periods available· newest 2025-12-31
- Shares outstanding: 9 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+7.1%Prior period
USD 125.91 million
–
Current period
USD 134.83 million
–
Exact inputs and evidence
134828000 − 125907000 = 8921000 USD
125907000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source134828000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 225.57 millionPrior period
−USD 100.71 million
–
Current period
USD 124.86 million
–
Exact inputs and evidence
124858000 − -100710000 = 225568000 USD
-100710000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source124858000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 55.32 millionPrior period
−USD 16.08 million
–
Current period
USD 39.25 million
–
Exact inputs and evidence
39246000 − -16076000 = 55322000 USD
-16076000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source39246000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%Prior period
USD 54,000
–
Current period
USD 0
–
Exact inputs and evidence
0 − 54000 = -54000 USD
54000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source0 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 134.83 million 100% of revenue
- Cost of revenue USD 66.48 million 49% of revenue
- Operating expenses USD 27.56 million 20% of revenue
- Operating income USD 40.79 million 30% of revenue
- Tax, interest and other Derived −USD 84.07 million −62% of revenue
- Net income USD 124.86 million 93% of revenue
Cash
- Operating cash flow USD 39.25 million 29% of revenue
- Capital expenditure USD 0 0% of revenue
- Free cash flow Derived USD 39.25 million 29% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2017 Operating loss: operating costs were 8,346% of revenue.
- 2018 Operating loss: operating costs were 346% of revenue.
- 2019 Operating loss: operating costs were 177% of revenue.
- 2020 Operating loss: operating costs were 156% of revenue.
- 2021 Operating loss: operating costs were 145% of revenue.
- 2022 Operating loss: operating costs were 125% of revenue.
- 2023 Operating loss: operating costs were 112% of revenue.
- 2024 Net loss: net income was −80% of revenue.
- 2025 Net income was higher than operating income, so the split is not drawn.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2017 2017-01-01 – 2017-12-31 | 76995 | 6426333 Derived | -6349338 | -65025 Derived | -6284313 | -4253873 Derived | Source
|
| 2018 2018-01-01 – 2018-12-31 | 5700199 | 19714071 Derived | -14013872 | 12054011 Derived | -26067883 | -7449305 Derived | Source
|
| 2019 2019-01-01 – 2019-12-31 | 53343310 | 94152807 Derived | -40809497 | -2308128 Derived | -38501369 | -57105069 Derived | Source
|
| 2020 2020-01-01 – 2020-12-31 | 128032397 | 199219530 Derived | -71187133 | 18044830 Derived | -89231963 | -33506590 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 189140000 | 273419000 Derived | -84279000 | 5661000 Derived | -89940000 | -15106000 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 220935000 | 276818000 Derived | -55883000 | 14975000 Derived | -70858000 | -11834000 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 143630000 | 161090000 Derived | -17460000 | 38122000 Derived | -55582000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 125907000 | 118038000 Derived | 7869000 | 108579000 Derived | -100710000 | -16130000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 134828000 | 94037000 Derived | 40791000 | -84067000 Derived | 124858000 | 39246000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 134.8M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Revenue | 76995 |
|
| 2018 | Revenue | 5700199 |
|
| 2019 | Revenue | 53343310 |
|
| 2020 | Revenue | 128032397 |
|
| 2021 | Revenue | 189140000 |
|
| 2022 | Revenue | 220935000 |
|
| 2023 | Revenue | 143630000 |
|
| 2024 | Revenue | 125907000 |
|
| 2025 | Revenue | 134828000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
7.1% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Year over year | No prior comparable period |
|
| 2018 | Year over year | 7,303.3% |
|
| 2019 | Year over year | 835.8% |
|
| 2020 | Year over year | 140% |
|
| 2021 | Year over year | 47.7% |
|
| 2022 | Year over year | 16.8% |
|
| 2023 | Year over year | -35% |
|
| 2024 | Year over year | -12.3% |
|
| 2025 | Year over year | 7.1% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 30.3% 2025
Net margin 92.6% 2025
Free cash flow margin 29.1% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Operating margin | -8,246.4% |
|
| 2018 | Operating margin | -245.8% |
|
| 2019 | Operating margin | -76.5% |
|
| 2020 | Operating margin | -55.6% |
|
| 2021 | Operating margin | -44.6% |
|
| 2022 | Operating margin | -25.3% |
|
| 2023 | Operating margin | -12.2% |
|
| 2024 | Operating margin | 6.2% |
|
| 2025 | Operating margin | 30.3% |
|
| 2017 | Net margin | -8,162% |
|
| 2018 | Net margin | -457.3% |
|
| 2019 | Net margin | -72.2% |
|
| 2020 | Net margin | -69.7% |
|
| 2021 | Net margin | -47.6% |
|
| 2022 | Net margin | -32.1% |
|
| 2023 | Net margin | -38.7% |
|
| 2024 | Net margin | -80% |
|
| 2025 | Net margin | 92.6% |
|
| 2017 | Free cash flow margin | -5,524.9% |
|
| 2018 | Free cash flow margin | -130.7% |
|
| 2019 | Free cash flow margin | -107.1% |
|
| 2020 | Free cash flow margin | -26.2% |
|
| 2021 | Free cash flow margin | -8% |
|
| 2022 | Free cash flow margin | -5.4% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | -12.8% |
|
| 2025 | Free cash flow margin | 29.1% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 39.2M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Operating cash flow | -4194392 |
|
| 2018 | Operating cash flow | -7417680 |
|
| 2019 | Operating cash flow | -56954306 |
|
| 2020 | Operating cash flow | -32294587 |
|
| 2021 | Operating cash flow | -14729000 |
|
| 2022 | Operating cash flow | -11304000 |
|
| 2023 | Operating cash flow | -24772000 |
|
| 2024 | Operating cash flow | -16076000 |
|
| 2025 | Operating cash flow | 39246000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD 39.2M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2017 | Free cash flow | -4253873 |
|
| 2018 | Free cash flow | -7449305 |
|
| 2019 | Free cash flow | -57105069 |
|
| 2020 | Free cash flow | -33506590 |
|
| 2021 | Free cash flow | -15106000 |
|
| 2022 | Free cash flow | -11834000 |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | -16130000 |
|
| 2025 | Free cash flow | 39246000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
104.3% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Liabilities / assets | 52% |
|
| 2018 | Liabilities / assets | 79.8% |
|
| 2019 | Liabilities / assets | 90.6% |
|
| 2020 | Liabilities / assets | 100.9% |
|
| 2021 | Liabilities / assets | 121.7% |
|
| 2022 | Liabilities / assets | 119.1% |
|
| 2023 | Liabilities / assets | 131.1% |
|
| 2024 | Liabilities / assets | 211.9% |
|
| 2025 | Liabilities / assets | 104.3% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
2.1× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2017 | Current assets / current liabilities | 9.27× |
|
| 2018 | Current assets / current liabilities | 0.44× |
|
| 2019 | Current assets / current liabilities | 0.55× |
|
| 2020 | Current assets / current liabilities | 0.69× |
|
| 2021 | Current assets / current liabilities | 0.67× |
|
| 2022 | Current assets / current liabilities | 0.36× |
|
| 2023 | Current assets / current liabilities | 0.38× |
|
| 2024 | Current assets / current liabilities | 0.33× |
|
| 2025 | Current assets / current liabilities | 2.1× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2015-01-01 – 2015-12-31 | −USD 197,138 Exact valueExact value: -197138 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 153,244 Exact valueExact value: -153244 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | −USD 6.28 million Exact valueExact value: -6284313 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.19 million Exact valueExact value: -4194392 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 59,481 Exact valueExact value: 59481 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.25 million Calculation and evidence-4194392 − 59481 USD Exact free cash flow: -4253873 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2018-01-01 – 2018-12-31 | −USD 26.07 million Exact valueExact value: -26067883 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.42 million Exact valueExact value: -7417680 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 31,625 Exact valueExact value: 31625 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 7.45 million Calculation and evidence-7417680 − 31625 USD Exact free cash flow: -7449305 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2019-01-01 – 2019-12-31 | −USD 38.5 million Exact valueExact value: -38501369 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 56.95 million Exact valueExact value: -56954306 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 150,763 Exact valueExact value: 150763 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 57.11 million Calculation and evidence-56954306 − 150763 USD Exact free cash flow: -57105069 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2020-01-01 – 2020-12-31 | −USD 89.23 million Exact valueExact value: -89231963 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 32.29 million Exact valueExact value: -32294587 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.21 million Exact valueExact value: 1212003 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 33.51 million Calculation and evidence-32294587 − 1212003 USD Exact free cash flow: -33506590 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 89.94 million Exact valueExact value: -89940000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14.73 million Exact valueExact value: -14729000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 377,000 Exact valueExact value: 377000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.11 million Calculation and evidence-14729000 − 377000 USD Exact free cash flow: -15106000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 70.86 million Exact valueExact value: -70858000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.3 million Exact valueExact value: -11304000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 530,000 Exact valueExact value: 530000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 11.83 million Calculation and evidence-11304000 − 530000 USD Exact free cash flow: -11834000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 55.58 million Exact valueExact value: -55582000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.77 million Exact valueExact value: -24772000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 100.71 million Exact valueExact value: -100710000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.08 million Exact valueExact value: -16076000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 54,000 Exact valueExact value: 54000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.13 million Calculation and evidence-16076000 − 54000 USD Exact free cash flow: -16130000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | USD 124.86 million Exact valueExact value: 124858000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 39.25 million Exact valueExact value: 39246000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 39.25 million Calculation and evidence39246000 − 0 USD Exact free cash flow: 39246000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
135 filings · 6,195 latest values · 6,195 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000894871, 894871, AREN, ISSM, MVEN, PAAI, edgar:894871, issm
Also known as Arena Group Holdings, Inc., INTEGRATED SURGICAL SYSTEMS INC, Paradium.AI, Inc., THE ARENA GROUP HOLDINGS, INC, THE ARENA GROUP HOLDINGS, INC., THEMAVEN, INC., theMaven, Inc., theMaven, Inc.